These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22827528)

  • 21. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiles differ markedly in mouse strains that are (or are not) susceptible to hyperthyroidism induced using thyrotropin receptor-expressing adenovirus.
    Chen CR; Abbud R; Wang C; Tan Y; Rapoport B; McLachlan SM
    Thyroid; 2005 Nov; 15(11):1229-37. PubMed ID: 16356085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice.
    Flynn JC; Gilbert JA; Meroueh C; Snower DP; David CS; Kong YC; Banga JP
    Immunology; 2007 Oct; 122(2):261-7. PubMed ID: 17535305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.
    Saitoh O; Mizutori Y; Takamura N; Yamasaki H; Kita A; Kuwahara H; Nagayama Y
    Clin Exp Immunol; 2005 Sep; 141(3):405-11. PubMed ID: 16045729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
    Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attempt to induce "Graves' disease of the gonads" by immunizing mice with the luteinizing hormone receptor provides insight into breaking tolerance to self-antigens.
    Chen CR; Aliesky HA; Rapoport B; McLachlan SM
    Thyroid; 2011 Jul; 21(7):773-81. PubMed ID: 21649471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
    Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
    Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
    Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor.
    Hoshina M; Ojima S; Kawasaki A; Doi K; Ohta S; Inoue A; Murayama H
    J Immunol Methods; 2024 May; 528():113655. PubMed ID: 38447802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
    Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
    Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid antigens, not central tolerance, control responses to immunization in BALB/c versus C57BL/6 mice.
    Misharin AV; Rapoport B; McLachlan SM
    Thyroid; 2009 May; 19(5):503-9. PubMed ID: 19348579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.
    Holthoff HP; Goebel S; Li Z; Faßbender J; Reimann A; Zeibig S; Lohse MJ; Münch G; Ungerer M
    Endocrinology; 2015 Apr; 156(4):1577-89. PubMed ID: 25562617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation.
    Allelein S; Diana T; Ehlers M; Kanitz M; Hermsen D; Schott M; Kahaly GJ
    Horm Metab Res; 2019 Jun; 51(6):341-346. PubMed ID: 31207654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
    Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
    Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.